Friedrich Marks

9.8k citations
241 papers · 8.7k · 1 hit paper · h-index 52

Impact in

  • Pharmacology top 0.2%
    • Inflammatory mediators and NSAID effects
    • NF-κB Signaling Pathways
    • Carcinogens and Genotoxicity Assessment

Papers in

    • Protein Kinase Regulation and GTPase Signaling 43
    • Peroxisome Proliferator-Activated Receptors 15
    • Retinoids in leukemia and cellular processes 12
    • Inflammatory mediators and NSAID effects 39

Friedrich Marks

236 papers receiving 8.2k citations

Friedrich Marks's Hit Papers

Rottlerin, a Novel Protein Kinase Inhibitor 1994 · 780 citations
7800+10+21Years since publication250500750

Peers

Friedrich Marks
Comparison fields: 5 of 136
  • Pharmacology 1.5k
  • Cancer Research 1.3k
  • Biochemistry 656
  • Dermatology 720
  • Molecular Biology 4.9k
Replace Gerhard Fürstenberger with:
Gerhard Fürstenberger Germany
John DiGiovanni United States
Michael Karin United States
Richard A. Heyman United States
Jesper Z. Haeggström Sweden
R. K. Boutwell United States
Hiroyasu Inoue Japan
Joël Raingeaud France
Jilly F. Evans United States
Ralf Schreck Germany
Friedrich Marks relative to Gerhard Fürstenberger Germany Gerhard Fürstenberger's profile →
Citations per field
00.5×1.5×
Gerhard Fürstenberger · 1×
Citations per year

Countries citing papers authored by Friedrich Marks

Since Specialization
Citations

This map shows the geographic impact of Friedrich Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Marks more than expected).

Fields of papers citing papers by Friedrich Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedrich Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Marks. The network helps show where Friedrich Marks may publish in the future.

Co-authors

The 25 scholars most cited alongside Friedrich Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Friedrich Marks Line = papers co-authored together Friedrich Marks links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 241 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rottlerin, a Novel Protein Kinase Inhibitor
Hit paper breakdown →
1994780
2 2002216
3 1981182
4 2001180
5 1995136
6 1983136
7 1980132
8 1988115
9 1991113
10 1977112
11 1999110
12
Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A 23187 and by tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
1981104
13 1987103
14 1998102
15
Effect of tumor-promoting phorbol esters and of acetic acid on mechanisms controlling DNA synthesis and mitosis (Chalones) and on the biosynthesis of histidine-rich protein in mouse epidermis.
1974101
16 1989100
17 199498
18 200098
19 199797
20 199194

About Friedrich Marks

Friedrich Marks is a scholar working on Molecular Biology, Pharmacology, Genetics, Cancer Research and Cell Biology, having authored 241 papers that have together received 8.7k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (43 papers), Inflammatory mediators and NSAID effects (39 papers), Estrogen and related hormone effects (35 papers), Skin and Cellular Biology Research (18 papers), Peroxisome Proliferator-Activated Receptors (15 papers), Eicosanoids and Hypertension Pharmacology (14 papers), NF-κB Signaling Pathways (14 papers) and Retinoids in leukemia and cellular processes (12 papers). The work is most often cited by research in Pharmacology (1.5k citations), Cancer Research (1.3k citations), Biochemistry (656 citations), Dermatology (720 citations) and Molecular Biology (4.9k citations). Friedrich Marks has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Gerhard Fürstenberger, Michael Gschwendt, Walter Kittstein, Karin Müller‐Decker, Gabriele Rincke, Peter Krieg, E. Hecker, H.-J. Müller, Rukun Zang and Friedemann Horn. Their work appears in journals such as Carcinogenesis, Biochemical and Biophysical Research Communications, FEBS Letters, Journal of Biological Chemistry and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact